| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6000273 | Seminars in Vascular Surgery | 2014 | 4 Pages |
Abstract
The clinical application of serum biomarkers (d-dimer, C-reactive protein) to predict the natural history of descending thoracic aortic dissection remains elusive. In this review, our current understanding of biomarkers in descending thoracic aortic dissection detection, predicting complications, and aiding in patient management is discussed.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sherene MD, MPH, Anahita MD, MS, MBA, Jared BA,